As mentioned earlier (see Section 3), PanIN progression mechanisms involve mutations in tumor-suppressing genes that lead to the activation of TGFβ signaling pathways (SMAD4/TGFBR1/TGFBR2). The gene discussed is SMAD4; the disease is neoplasm.